Everolimus plus exemestane improves bone health in post-menopausal women with ... Science Codex Vienna, Austria: Results from a phase III clinical trial evaluating a new treatment for breast cancer in post-menopausal women show that the combination of two cancer drugs, everolimus and exemestane, significantly improves bone strength and reduces ... |